Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinoma
View abstract on PubMed
Summary
This summary is machine-generated.Researchers identified a new cancer-associated fibroblast (CAF) subtype, F5-CAF, in liver cancer. This F5-CAF promotes cancer stemness and is linked to worse patient prognosis, offering insights into liver cancer development.
Area Of Science
- Oncology
- Cancer Biology
- Tumor Microenvironment Research
Background
- Cancer-associated fibroblasts (CAFs) are key components of the tumor microenvironment (TME).
- Specific CAF roles in coordinating liver TME cell populations for cancer progression are not fully understood.
Purpose Of The Study
- To identify and characterize CAF subpopulations within the liver TME.
- To elucidate the spatial distribution and functional impact of CAFs on hepatocellular carcinoma (HCC) progression.
Main Methods
- Integrated multi-region proteomics, spatial transcriptomics (10X Genomics Visium), and multiplexed imaging.
- Validation of identified CAF subpopulations through cell isolation and in vitro functional assays.
Main Results
- A novel CAF subpopulation, F5-CAF (marked by COL1A2, COL4A1, COL4A2, CTGF, FSTL1), was identified in liver cancer.
- F5-CAFs colocalize with stem-like cancer cells in HCC and are associated with worse prognosis in patients.
- In vitro studies confirmed F5-CAFs promote HCC cell proliferation and stemness.
Conclusions
- A distinct F5-CAF subpopulation in liver cancer is linked to cancer stemness and poor prognosis.
- This CAF subset may promote liver cancer development by supporting cancer stem cell survival within the TME.
Related Concept Videos
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

